Cytomegalovirus seropositivity is associated with herpes zoster

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 6, 2015, Pages 1394-1399

  Ogunjimi, Benson ^a,b   Hens, Niel ^a,b   Pebody, Richard ^c   Jansens, Hilde ^d   Seale, Holly ^e   Quinlivan, Mark ^f   Theeten, Heidi ^a   Goossens, Herman ^a,d   Breuer, Judy ^f   Beutels, Philippe ^a,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CMV; Immunosenescence; Reactivation; Shingles; Susceptibility; Zoster

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL EVALUATION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SEROPREVALENCE; STATISTICAL ANALYSIS; ADOLESCENT; AGED; AUSTRALIA; BLOOD; COMPLICATION; CYTOMEGALOVIRUS; EUROPE; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; RISK ASSESSMENT; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; AUSTRALIA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EUROPE; FEMALE; HERPES ZOSTER; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84944449380     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1037999     Document Type: Article

References (30)

1. Dolin R, Reichman RC, Mazur MH, Whitley RJ. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 1978; 89:375- 88; PMID:210697; http://dx. doi. org/10. 7326/0003- 4819-89-3-375
2. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008; 197:825-35; PMID:18419349; http://dx. doi. org/10. 1086/528696
3. Hope-Simpson RE. The nature of herpes zoster: a longterm study and a new hypothesis. Proc R Soc Med 1965; 58:9-20; PMID:14267505
4. Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One 2013; 8:e66485; PMID:23805224; http://dx. doi. org/ 10. 1371/journal. pone. 0066485
5. Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ 2014; 348:g2911; PMID:25134101; http://dx. doi. org/10. 1136/bmj. g2911
6. Ogunjimi B, Buntinx F, Bartholomeeusen S, Terpstra I, De Haes I, Willem L, Elli S, Bilcke J, Van Damme P, Coenen S, et al. Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. J Infect 2015; 70:171-7; PMID:25218425; http://dx. doi. org/10. 1016/j. jinf. 2014. 08. 016
7. Meysman P, Ogunjimi B, Naulaerts S, Beutels P, Van Tendeloo V, Laukens K. Varicella-zoster virus-derived major histocompatibility complex class I-Restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia. J Virol 2015; 89:962-9; PMID:25355886; http://dx. doi. org/10. 1128/JVI. 02500-14
8. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175:8218-25; PMID:16339561; http://dx. doi. org/10. 4049/jimmunol. 175. 12. 8218
9. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012; 24:507-11; PMID:22541724; http://dx. doi. org/10. 1016/j. coi. 2012. 04. 002
10. Ogunjimi B, Theeten H, Hens N, Beutels P. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. J Med Virol 2014; 86:812-9; PMID:24037981; http://dx. doi. org/ 10. 1002/jmv. 23749
11. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J Med Virol 2012; 84:1797-802; PMID:22997083; http://dx. doi. org/ 10. 1002/jmv. 23397
12. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 2009; 137:58-65; PMID:18413004; http://dx. doi. org/ 10. 1017/S0950268808000551
13. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014; 4: e004833; PMID:24916088; http://dx. doi. org/ 10. 1136/bmjopen-2014-004833
14. Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort. Clin Infect Dis 2013; 56:1421-7; PMID:23442763; http://dx. doi. org/10. 1093/cid/cit083
15. Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, et al. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 2010; 171:1144-52; PMID:20400465; http://dx. doi. org/ 10. 1093/aje/kwq062
16. Mehta SK, Stowe RP, Feiveson AH, Tyring SK, Pierson DL. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000; 182:1761-4; PMID:11069250; http://dx. doi. org/ 10. 1086/317624
17. Vyse AJ, Hesketh LM, Pebody RG. The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy? Epidemiol Infect 2009; 137:526-33; PMID:18789177; http://dx. doi. org/10. 1017/S0950268808001258
18. Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011; 21:240-55; PMID:21674676; http://dx. doi. org/ 10. 1002/rmv. 695
19. Bilcke J, van Hoek AJ, Beutels P. Childhood varicellazoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? Hum Vaccin Immunother 2013; 9:812-22; PMID:23321955; http://dx. doi. org/10. 4161/hv. 23334
20. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; http://dx. doi. org/10. 1056/NEJMoa051016
21. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4:26-33; PMID:14720565; http://dx. doi. org/ 10. 1016/S1473-3099(03)00857-0
22. Yawn BP, Saddier P, Wollan PC, Sauver JLS, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341-9; PMID:17976353; http://dx. doi. org/10. 4065/82. 11. 1341
23. Loeth N, Assing K, Madsen HO, Vindelov L, Buus S, Stryhn A. Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors. PLoS One 2012; 7:e31420; PMID:22347475; http://dx. doi. org/10. 1371/journal. pone. 0031420
24. Ogunjimi B, Smits E, Heynderickx S, Van den Bergh J, Bilcke J, Jansens H, Malfait R, Ramet J, Maecker HT, Cools N, et al. Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians. Clin Vaccine Immunol 2014; 21:417-26; PMID:24429070; http:// dx. doi. org/10. 1128/CVI. 00818-13
25. Quinlivan M, Hawrami K, Barrett-Muir W, Aaby P, Arvin A, Chow VT, John TJ, Matondo P, Peiris M, Poulsen A, et al. The molecular epidemiology of varicella- zoster virus: evidence for geographic segregation. J Infect Dis 2002; 186:888-94; PMID:12232828; http://dx. doi. org/10. 1086/344228
26. Quinlivan ML, Ayres KL, Kelly PJ, Parker SP, Scott FT, Johnson RW, Maple C, Breuer J. Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 2011; 50:130-5; PMID:21093356; http://dx. doi. org/10. 1016/j. jcv. 2010. 10. 014
27. Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect 2011; 139:494-504; PMID:20587123; http://dx. doi. org/ 10. 1017/S0950268810001536
28. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010; 50:1439-47; PMID:20426575; http://dx. doi. org/10. 1086/652438
29. Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L. National serosurvey of cytomegalovirus in Australia. Clin Vaccine Immunol 2006; 13:1181-4; PMID:16957061; http://dx. doi. org/ 10. 1128/CVI. 00203-06
30. Prince HE, Lape-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol 2014; 21:1377-84; PMID:25165026; http://dx. doi. org/10. 1128/CVI. 00487-14